NYSE:CO - China Cord Blood Stock Price, Price Target & More

$9.28 -0.04 (-0.43 %)
(As of 04/22/2018 04:00 PM ET)
Previous Close$9.28
Today's Range$9.24 - $9.35
52-Week Range$6.65 - $14.95
Volume163,875 shs
Average Volume234,251 shs
Market Capitalization$1.12 billion
P/E Ratio27.29
Dividend YieldN/A
Beta0.9

About China Cord Blood (NYSE:CO)

China Cord Blood logoChina Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants. As of March 31, 2016, the Company had three operating cord blood banks.

Receive CO News and Ratings via Email

Sign-up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Holding & other investment offices
Sub-IndustryN/A
SectorMedical
SymbolNYSE:CO
CUSIPN/A
Phone852-3605-8180

Debt

Debt-to-Equity RatioN/A
Current Ratio9.28%
Quick Ratio9.20%

Price-To-Earnings

Trailing P/E Ratio27.29
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$110.41 million
Price / Sales10.14
Cash Flow$0.3276 per share
Price / Cash28.33
Book Value$3.34 per share
Price / Book2.78

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$18.33 million
Net Margins27.05%
Return on Equity9.05%
Return on Assets4.49%

Miscellaneous

Employees1,059
Outstanding Shares120,610,000

How to Become a New Pot Stock Millionaire

China Cord Blood (NYSE:CO) Frequently Asked Questions

What is China Cord Blood's stock symbol?

China Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."

How were China Cord Blood's earnings last quarter?

China Cord Blood Corp (NYSE:CO) released its quarterly earnings data on Monday, February, 26th. The medical research company reported $0.09 EPS for the quarter. The medical research company had revenue of $37.65 million for the quarter. China Cord Blood had a return on equity of 9.05% and a net margin of 27.05%. View China Cord Blood's Earnings History.

When is China Cord Blood's next earnings date?

China Cord Blood is scheduled to release their next quarterly earnings announcement on Wednesday, June, 20th 2018. View Earnings Estimates for China Cord Blood.

Who are some of China Cord Blood's key competitors?

Who are China Cord Blood's key executives?

China Cord Blood's management team includes the folowing people:
  • Yuen Kam, Chairman of the Board (Age 53)
  • Ting Zheng, Chief Executive Officer, Director, Chief Executive Officer - Beijing (Age 43)
  • Albert Chen, Chief Financial Officer, Director (Age 39)
  • Rui Arashiyama, Chief Executive Officer - Guangdong and Zhejiang Divisions (Age 56)
  • Xin Xu, Chief Technology Officer (Age 61)
  • Mark D. Chen, Independent Non-Executive Director (Age 47)
  • Ken Lu, Independent Non-Executive Director (Age 51)
  • Jennifer J. Weng, Independent Non-Executive Director (Age 47)

Has China Cord Blood been receiving favorable news coverage?

News articles about CO stock have been trending somewhat positive on Sunday, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. China Cord Blood earned a media sentiment score of 0.16 on Accern's scale. They also gave news articles about the medical research company an impact score of 47.19 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of China Cord Blood?

Shares of CO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is China Cord Blood's stock price today?

One share of CO stock can currently be purchased for approximately $9.28.

How big of a company is China Cord Blood?

China Cord Blood has a market capitalization of $1.12 billion and generates $110.41 million in revenue each year. China Cord Blood employs 1,059 workers across the globe.

How can I contact China Cord Blood?

China Cord Blood's mailing address is 48TH FLOOR BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The medical research company can be reached via phone at 852-3605-8180 or via email at [email protected]


MarketBeat Community Rating for China Cord Blood (CO)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  134 (Vote Outperform)
Underperform Votes:  158 (Vote Underperform)
Total Votes:  292
MarketBeat's community ratings are surveys of what our community members think about China Cord Blood and other stocks. Vote "Outperform" if you believe CO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CO will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

China Cord Blood (NYSE:CO) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
(Data available from 4/22/2016 forward)

Earnings

China Cord Blood (NYSE:CO) Earnings History and Estimates Chart

Earnings by Quarter for China Cord Blood (NYSE:CO)

China Cord Blood (NYSE CO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/19/2018$0.13N/AView Earnings Details
2/26/2018Q3 2018$0.09$37.65 millionViewN/AView Earnings Details
11/20/2017Q2 2018$0.09$35.26 millionViewN/AView Earnings Details
8/23/20176/30/2017$0.09$33.07 millionViewN/AView Earnings Details
6/21/20173/31/2017$0.05$0.07$29.35 millionViewN/AView Earnings Details
2/24/2017Q317$0.04$0.10$28.93 millionViewListenView Earnings Details
11/17/2016Q217$0.04$0.03$27.37 million$27.61 millionViewListenView Earnings Details
8/22/2016Q117$0.03$0.03$26.23 million$26.00 millionViewN/AView Earnings Details
6/14/2016Q416$0.03$0.03$25.87 million$24.31 millionViewListenView Earnings Details
2/29/2016Q3 2016$0.05$0.10$26.97 million$26.15 millionViewN/AView Earnings Details
11/23/2015Q216$0.04$0.05$26.42 million$27.00 millionViewListenView Earnings Details
8/19/2015Q116$0.04$0.03$25.81 million$26.70 millionViewListenView Earnings Details
6/18/2015Q415$0.05$0.04$25.88 million$26.30 millionViewListenView Earnings Details
2/25/2015Q315$0.06$0.07$26.35 million$26.90 millionViewListenView Earnings Details
11/25/2014Q2$0.06$0.06$25.30 million$24.78 millionViewListenView Earnings Details
8/28/2014Q1$0.06$0.06$24.78 million$24.72 millionViewListenView Earnings Details
6/18/2014Q414$0.07$0.07$24.41 million$24.44 millionViewN/AView Earnings Details
2/24/2014Q3$0.06$0.07$24.22 million$24.90 millionViewListenView Earnings Details
1/31/2014Q4($0.25)ViewN/AView Earnings Details
11/15/2013Q2$0.06$0.06$22.32 million$23.10 millionViewListenView Earnings Details
8/26/2013Q1 2014$0.04$0.07$21.62 million$21.00 millionViewListenView Earnings Details
6/18/2013Q4 2013$0.02$0.05$16.59 million$21.40 millionViewListenView Earnings Details
2/26/2013Q3 2013$0.05$0.07ViewN/AView Earnings Details
11/19/2012Q312$0.05$18.53 million$20.40 millionViewN/AView Earnings Details
8/22/2012Q1 2013$0.04$0.06ViewN/AView Earnings Details
6/11/2012Q4 2012$0.06$0.06ViewN/AView Earnings Details
2/27/2012Q3 2012$0.06$0.09ViewN/AView Earnings Details
11/28/2011Q2 2012$0.06$0.05ViewN/AView Earnings Details
8/29/2011Q1 2012$0.05$0.08ViewN/AView Earnings Details
6/10/2011Q4 2011$0.05$0.05ViewN/AView Earnings Details
2/28/2011Q3 2011$0.04$0.06ViewN/AView Earnings Details
11/24/2010Q2 2011$0.04$0.05ViewN/AView Earnings Details
9/10/2010Q1 2011$0.04$0.04ViewN/AView Earnings Details
6/22/2010Q4 2010$0.04$0.03ViewN/AView Earnings Details
3/5/2010Q2 2010$0.04ViewN/AView Earnings Details
12/11/2009Q1 2010$0.04ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

China Cord Blood (NYSE:CO) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

China Cord Blood (NYSE CO) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 21.95%
Insider Trading History for China Cord Blood (NYSE:CO)
Institutional Ownership by Quarter for China Cord Blood (NYSE:CO)

China Cord Blood (NYSE CO) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/5/2016Gordon Scott Townsen MckinnonDirectorBuy500,000$0.02$10,000.00
9/30/2015Fraser James LaschingerInsiderBuy80,000$0.0150$1,200.00
9/30/2015Gordon Scott Townsen MckinnonDirectorBuy50,000$0.0150$750.00
9/29/2015Gordon Scott Townsen MckinnonDirectorBuy1,000$0.0250$25.00
1/21/2015Kent C MccarthyInsiderBuy20,000$4.60$92,000.00View SEC Filing  
1/16/2015Kent C MccarthyInsiderBuy50,000$4.30$215,000.00View SEC Filing  
1/14/2015Private Equity Fund Jayhawk IIInsiderBuy10,000$4.52$45,200.00View SEC Filing  
1/12/2015Private Equity Fund Jayhawk IIInsiderBuy50,000$4.69$234,500.00View SEC Filing  
11/28/2014Robert Douglas CudneyInsiderBuy200,000$0.0050$1,000.00
11/17/2014Kent C MccarthyInsiderBuy26,754$4.70$125,743.80View SEC Filing  
11/6/2014Kent C MccarthyInsiderBuy150,000$5.16$774,000.00View SEC Filing  
9/29/2014Kent C MccarthyInsiderBuy10,000$5.00$50,000.00View SEC Filing  
9/10/2014Kent C MccarthyInsiderBuy9,900$4.98$49,302.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

China Cord Blood (NYSE CO) News Headlines

Source:
DateHeadline
China Cord Blood (CO) Lifted to Strong-Buy at BidaskClubChina Cord Blood (CO) Lifted to Strong-Buy at BidaskClub
www.americanbankingnews.com - April 14 at 6:22 PM
Universal Business Payment Solutions Acquisition (JTPY) vs. China Cord Blood (CO) Critical SurveyUniversal Business Payment Solutions Acquisition (JTPY) vs. China Cord Blood (CO) Critical Survey
www.americanbankingnews.com - April 14 at 5:43 AM
China Cord Blood (CO) vs. AgroFresh Solutions (AGFS) Head-To-Head ReviewChina Cord Blood (CO) vs. AgroFresh Solutions (AGFS) Head-To-Head Review
www.americanbankingnews.com - April 10 at 9:34 PM
Analyzing China Cord Blood (CO) & ConvergeOne (CVON)Analyzing China Cord Blood (CO) & ConvergeOne (CVON)
www.americanbankingnews.com - April 10 at 7:09 PM
Financial Analysis: AgroFresh Solutions (AGFS) and China Cord Blood (CO)Financial Analysis: AgroFresh Solutions (AGFS) and China Cord Blood (CO)
www.americanbankingnews.com - April 4 at 3:20 PM
Head-To-Head Survey: AgroFresh Solutions (AGFS) versus China Cord Blood (CO)Head-To-Head Survey: AgroFresh Solutions (AGFS) versus China Cord Blood (CO)
www.americanbankingnews.com - April 2 at 3:06 AM
Cord Blood Banking Market to Gain From Enhanced Application in Genetic Disease Treatment: Radiant Insights, Inc.Cord Blood Banking Market to Gain From Enhanced Application in Genetic Disease Treatment: Radiant Insights, Inc.
finance.yahoo.com - March 27 at 10:07 AM
BRIEF-Nanjing Xinjiekou Department Store Clarifies Media Reports On Investment In Unit China Cord BloodBRIEF-Nanjing Xinjiekou Department Store Clarifies Media Reports On Investment In Unit China Cord Blood
finance.yahoo.com - March 23 at 9:35 AM
BRIEF-China Cord Blood Says Shareholders Approved Cos Name ChangeBRIEF-China Cord Blood Says Shareholders Approved Co's Name Change
www.reuters.com - March 16 at 5:14 PM
China Cord Blood to become Global Cord Blood March 22China Cord Blood to become Global Cord Blood March 22
seekingalpha.com - March 16 at 5:14 PM
Should You Be Tempted To Sell China Cord Blood Corporation (NYSE:CO) At Its Current PE Ratio?Should You Be Tempted To Sell China Cord Blood Corporation (NYSE:CO) At Its Current PE Ratio?
finance.yahoo.com - March 16 at 5:14 PM
China Cord Blood Corporation Announces Results of Extraordinary General Meeting of Shareholders to Change Company Name to "Global Cord Blood Corporation"China Cord Blood Corporation Announces Results of Extraordinary General Meeting of Shareholders to Change Company Name to "Global Cord Blood Corporation"
finance.yahoo.com - March 16 at 9:58 AM
Quinn Opportunity Partners LLC Has $1.01 Million Holdings in China Cord Blood Corp (CO)Quinn Opportunity Partners LLC Has $1.01 Million Holdings in China Cord Blood Corp (CO)
www.americanbankingnews.com - March 5 at 12:34 PM
China Cord Blood Corp (CO) Shares Bought by Arrowstreet Capital Limited PartnershipChina Cord Blood Corp (CO) Shares Bought by Arrowstreet Capital Limited Partnership
www.americanbankingnews.com - March 3 at 4:24 AM
China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2018China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2018
finance.yahoo.com - February 26 at 4:50 PM
How Does China Cord Blood Corporation’s (NYSE:CO) Earnings Growth Stack Up Against Industry Performance?How Does China Cord Blood Corporation’s (NYSE:CO) Earnings Growth Stack Up Against Industry Performance?
finance.yahoo.com - February 26 at 4:50 PM
China Cord Blood (CO) to Release Quarterly Earnings on ThursdayChina Cord Blood (CO) to Release Quarterly Earnings on Thursday
www.americanbankingnews.com - February 15 at 1:44 AM
China Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2018 Financial ResultsChina Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2018 Financial Results
finance.yahoo.com - February 14 at 9:03 AM
China Cord Blood Corporation to Change Corporate Name to "Global Cord Blood Corporation"China Cord Blood Corporation to Change Corporate Name to "Global Cord Blood Corporation"
finance.yahoo.com - February 7 at 9:05 AM
Tempted to buy on sell-off? Pick a stock you like, says C...Tempted to buy on sell-off? Pick a stock you like, says C...
finance.yahoo.com - February 6 at 4:31 PM
Golden Meditech Acquires 16.14% Interest of Ying Peng Hui Kang FundGolden Meditech Acquires 16.14% Interest of Ying Peng Hui Kang Fund
www.bizjournals.com - February 5 at 9:01 AM
Nanjing Ying Peng Becomes Major Shareholder of China Cord Blood CorporationNanjing Ying Peng Becomes Major Shareholder of China Cord Blood Corporation
finance.yahoo.com - January 31 at 9:16 AM
Golden Meditech Completes Sale of Equity Interest in China Cord Blood CorporationGolden Meditech Completes Sale of Equity Interest in China Cord Blood Corporation
www.prnewswire.com - January 31 at 5:00 AM
Contrasting China Cord Blood (CO) and Laboratory Corp. of America (LH)Contrasting China Cord Blood (CO) and Laboratory Corp. of America (LH)
www.americanbankingnews.com - January 25 at 3:12 AM
Oversold Conditions For China Cord Blood (CO)Oversold Conditions For China Cord Blood (CO)
www.nasdaq.com - January 12 at 5:01 PM
China Cord Blood (CO) and Select Medical (SEM) Head-To-Head ComparisonChina Cord Blood (CO) and Select Medical (SEM) Head-To-Head Comparison
www.americanbankingnews.com - January 12 at 3:28 PM
China Cord Blood (CO) versus Laboratory Corp. of America (LH) Critical ComparisonChina Cord Blood (CO) versus Laboratory Corp. of America (LH) Critical Comparison
www.americanbankingnews.com - January 10 at 7:40 PM
Comparing China Cord Blood (CO) & The Providence Service (PRSC)Comparing China Cord Blood (CO) & The Providence Service (PRSC)
www.americanbankingnews.com - January 8 at 5:34 AM
ETFs with exposure to China Cord Blood Corp. : December 25, 2017ETFs with exposure to China Cord Blood Corp. : December 25, 2017
finance.yahoo.com - December 25 at 6:58 PM
How A Young Danish Speaker Startup Took OffHow A Young Danish Speaker Startup Took Off
finance.yahoo.com - December 19 at 9:40 AM
China Cord Blood Corp. :CO-US: Earnings Analysis: Q2, 2018 By the Numbers : December 18, 2017China Cord Blood Corp. :CO-US: Earnings Analysis: Q2, 2018 By the Numbers : December 18, 2017
finance.yahoo.com - December 18 at 5:09 PM
ETFs with exposure to China Cord Blood Corp. : December 13, 2017ETFs with exposure to China Cord Blood Corp. : December 13, 2017
finance.yahoo.com - December 13 at 5:22 PM
China Cord Blood (CO) versus HMS (HMSY) Critical ComparisonChina Cord Blood (CO) versus HMS (HMSY) Critical Comparison
www.americanbankingnews.com - December 11 at 7:16 PM
China Cord Blood Corporation Announces Results of 2017 Annual General MeetingChina Cord Blood Corporation Announces Results of 2017 Annual General Meeting
finance.yahoo.com - December 7 at 9:56 AM
Will China Cord Blood Corporation (CO) Continue To Underperform Its Industry?Will China Cord Blood Corporation (CO) Continue To Underperform Its Industry?
finance.yahoo.com - December 6 at 5:13 PM
China Cord Blood Corp. – Value Analysis (NYSE:CO) : November 24, 2017China Cord Blood Corp. – Value Analysis (NYSE:CO) : November 24, 2017
finance.yahoo.com - November 24 at 3:58 PM
Surgical Care Affiliates (SCAI) & China Cord Blood Corporation (CO) Head to Head ContrastSurgical Care Affiliates (SCAI) & China Cord Blood Corporation (CO) Head to Head Contrast
www.americanbankingnews.com - November 23 at 3:36 PM
China Cord Blood Corporation to Host Earnings CallChina Cord Blood Corporation to Host Earnings Call
finance.yahoo.com - November 23 at 4:10 AM
China Cord Blood Corp. breached its 50 day moving average in a Bullish Manner : CO-US : November 22, 2017China Cord Blood Corp. breached its 50 day moving average in a Bullish Manner : CO-US : November 22, 2017
finance.yahoo.com - November 22 at 6:05 PM
Edited Transcript of CO earnings conference call or presentation 21-Nov-17 1:00pm GMTEdited Transcript of CO earnings conference call or presentation 21-Nov-17 1:00pm GMT
finance.yahoo.com - November 21 at 10:36 PM
China Cord Bloods (CO) Management on Q2 2018 Results - Earnings Call TranscriptChina Cord Blood's (CO) Management on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - November 21 at 5:33 PM
China Cord Blood Corp Reports 306% Advance In Q2 EarningsChina Cord Blood Corp Reports 306% Advance In Q2 Earnings
www.rttnews.com - November 20 at 6:28 PM
China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2018China Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2018
finance.yahoo.com - November 20 at 6:28 PM
China Cord Blood posts 2Q profitChina Cord Blood posts 2Q profit
finance.yahoo.com - November 20 at 6:28 PM
China Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2018 Financial ResultsChina Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2018 Financial Results
finance.yahoo.com - November 13 at 10:35 PM
ETFs with exposure to China Cord Blood Corp. : November 10, 2017ETFs with exposure to China Cord Blood Corp. : November 10, 2017
finance.yahoo.com - November 10 at 5:13 PM
China Cord Blood Corporation (CO) Set to Announce Quarterly Earnings on WednesdayChina Cord Blood Corporation (CO) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - November 8 at 1:54 AM
Financial Review: Tenet Healthcare Corporation (THC) versus China Cord Blood Corporation (CO)Financial Review: Tenet Healthcare Corporation (THC) versus China Cord Blood Corporation (CO)
www.americanbankingnews.com - November 8 at 1:18 AM
BRIEF-Jayhawk Capital sends open letter to Sanpower Group regarding China Cord Blood CorpBRIEF-Jayhawk Capital sends open letter to Sanpower Group regarding China Cord Blood Corp
www.reuters.com - October 31 at 11:34 PM
October 31, 2017 Open Letter from Jayhawk Capital to Sanpower Group regarding China Cord Blood CorpOctober 31, 2017 Open Letter from Jayhawk Capital to Sanpower Group regarding China Cord Blood Corp
finance.yahoo.com - October 31 at 6:32 PM

SEC Filings

China Cord Blood (NYSE:CO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

China Cord Blood (NYSE:CO) Income Statement, Balance Sheet and Cash Flow Statement

Chart

China Cord Blood (NYSE CO) Stock Chart for Sunday, April, 22, 2018

Loading chart…

This page was last updated on 4/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.